Evidence map›Paper›PMID 39822170›Full record

GuidelineJournal of gastric cancer2025

Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline).

In-Ho Kim, Seung Joo Kang, Wonyoung Choi, An Na Seo, Bang Wool Eom, Beodeul Kang, Bum Jun Kim, Byung-Hoon Min, Chung Hyun Tae, Chang In Choi and 24 more

Registry-linked trialAbstract readPractice Guideline
In one paragraph

Guideline in Journal of gastric cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07161479 (A Multicenter, Randomized, Single-Blinded Trial Comparing Argon Plasma Coagulation and Endoscopic Mucosal Resection for Gastric Adenoma With Low-Grade Dysplasia), which is not on this map. Cited by 91 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07161479 narecruitingnot on this mapstarted 2026, after this paper: background citation

A Multicenter, Randomized, Single-Blinded Trial Comparing Argon Plasma Coagulation and Endoscopic Mucosal Resection for Gastric Adenoma With Low-Grade Dysplasia

TypeinterventionalSponsorSamsung Medical CenterRan2026 to 2026Enrolled160ConditionsGastric Adenoma, Stomach Neoplasms, Precancerous Conditions, Dysplasia StomachArmsArgon Plasma Coagulation (APC), Endoscopic Mucosal Resection (EMR)
3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Gastric Mucosa Cancer Risk: The Operative Link on Gastritis Assessment Staging System.The Korean journal of helicobacter and upper gastrointestinal research · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Tackling similarities and differences in global practice guidelines for gastric cancer: a review on the latest Taiwan guidelines with Asia-Pacific, European and US guidelines.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Review
  16. Simple clinical parameters to identify sarcopenia 1 year after gastrectomy for gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

In-Ho Kim *Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, The College of Medicine, The Catholic University of Korea, Seoul, Korea.ORCID 0000-0002-0351-2074
Seung Joo Kang *Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.ORCID 0000-0002-7401-8356
Wonyoung Choi *Center for Gastric Cancer, National Cancer Center, Goyang, Korea.ORCID 0000-0002-8292-3903
An Na SeoDepartment of Pathology, School of Medicine, Kyungpook National University, Daegu, Korea.ORCID 0000-0001-6412-3067
Bang Wool EomCenter for Gastric Cancer, National Cancer Center, Goyang, Korea.ORCID 0000-0002-0332-2051
Beodeul KangDivision of Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea.ORCID 0000-0001-5177-8937
Bum Jun KimDepartment of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Anyang, Korea.ORCID 0000-0003-2360-5160
Byung-Hoon MinDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID 0000-0001-8048-361X
Chung Hyun TaeDepartment of Internal Medicine, College of Medicine, Ewha Womans University, Seoul, Korea.ORCID 0000-0002-0764-7793
Chang In ChoiDepartment of Surgery, Pusan National University Hospital, Busan, Korea.ORCID 0000-0002-1920-1879
Choong-Kun LeeDivision of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.ORCID 0000-0001-5151-5096
Ho Jung AnDivision of Oncology, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.ORCID 0000-0003-0821-8365
Hwa Kyung ByunDepartment of Radiation Oncology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.ORCID 0000-0002-8964-6275
Hyeon-Su ImDepartment of Hematology and Oncology, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, Korea.ORCID 0000-0002-1393-4246
Hyung-Don KimDepartment of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.ORCID 0000-0001-9959-0642
Jang Ho ChoDivision of Medical Oncology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.ORCID 0000-0002-3429-4321
Kyoungjune PakDepartment of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.ORCID 0000-0001-5051-1894
Jae-Joon KimDivision of Hematology and Oncology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea.ORCID 0000-0003-1226-2537
Jae Seok BaeDepartment of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Korea.ORCID 0000-0003-2768-7917
Jeong Il YuDepartment of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Korea.ORCID 0000-0002-2009-7263
Jeong Won LeeDepartment of Nuclear Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.ORCID 0000-0002-2697-3578
Jungyoon ChoiDivision of Oncology/Hematology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.ORCID 0000-0001-9534-0400
Jwa Hoon KimDivision of Medical Oncology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.ORCID 0000-0002-0838-0111
Miyoung ChoiNational Evidence-based Healthcare Collaborating Agency (NECA), Seoul, Korea.ORCID 0000-0002-2424-9965
Mi Ran JungDepartment of Surgery, Chonnam National University Medical School, Gwangju, Korea.ORCID 0000-0002-7076-6998
Nieun SeoDepartment of Radiology, Yonsei University College of Medicine, Seoul, Korea.ORCID 0000-0001-8745-6454
Sang Soo EomDepartment of Surgery, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea.ORCID 0000-0002-6252-7532
Soomin AhnDepartment of Pathology and Translational Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID 0000-0002-1979-4010
Soo Jin KimDepartment of Radiology, National Cancer Center, Goyang, Korea.ORCID 0009-0001-3526-2751
Sung Hak LeeDepartment of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.ORCID 0000-0003-1020-5838
Sung Hee LimDivision of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Seoul, Korea.ORCID 0000-0003-0845-9994
Tae-Han KimDepartment of Surgery, Gyeongsang National University Changwon Hospital, Changwon, Korea. taehan.email@gmail.com.ORCID 0000-0002-5012-7208
Hye Sook HanDepartment of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea. hyesukhan@chungbuk.ac.kr.ORCID 0000-0001-6729-8700
Development Working Group for the Korean Practice Guideline for Gastric Cancer 2024 Task Force Team

Funding

National Cancer Center NCC-2112570
6 · The paper itself

Abstract

Gastric cancer is one of the most common cancers in both Korea and worldwide. Since 2004, the Korean Practice Guidelines for Gastric Cancer have been regularly updated, with the 4th edition published in 2022. The 4th edition was the result of a collaborative work by an interdisciplinary team, including experts in gastric surgery, gastroenterology, endoscopy, medical oncology, abdominal radiology, pathology, nuclear medicine, radiation oncology, and guideline development methodology. The current guideline is the 5th version, an updated version of the 4th edition. In this guideline, 6 key questions (KQs) were updated or proposed after a collaborative review by the working group, and 7 statements were developed, or revised, or discussed based on a systematic review using the MEDLINE, Embase, Cochrane Library, and KoreaMed database. Over the past 2 years, there have been significant changes in systemic treatment, leading to major updates and revisions focused on this area. Additionally, minor modifications have been made in other sections, incorporating recent research findings. The level of evidence and grading of recommendations were categorized according to the Grading of Recommendations, Assessment, Development and Evaluation system. Key factors for recommendation included the level of evidence, benefit, harm, and clinical applicability. The working group reviewed and discussed the recommendations to reach a consensus. The structure of this guideline remains similar to the 2022 version. Earlier sections cover general considerations, such as screening, diagnosis, and staging of endoscopy, pathology, radiology, and nuclear medicine. In the latter sections, statements are provided for each KQ based on clinical evidence, with flowcharts supporting these statements through meta-analysis and references. This multidisciplinary, evidence-based gastric cancer guideline aims to support clinicians in providing optimal care for gastric cancer patients.

Indexed as

Evidence-Based MedicineStomach NeoplasmsHumansRepublic of KoreaSystematic Reviews as TopicChemotherapyEndoscopyGuidelinesStomach neoplasmsSurgery

Identifiers

PMID39822170
PMCPMC11739648

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.